论文部分内容阅读
Cancer immunotherapies,including chimeric antigen receptor T cell therapy and checkpoint blocker therapy(PD-1/CTLA-4)have achieved revolutionary prognosis effect in clinic.However,these therapies are not suitable for all types of cancer,especially for those solid tumors.